Closing the Gap:
New Science, New HCP Expectations

Veeva Pulse Field Trends Report

As the pharmaceutical industry continues to adapt to HCP preferences and hybrid commercial models, it’s critical to stay on top of evolving field and HCP engagement trends.

Each quarter, the Veeva Pulse Field Trends Report provides unique insights into global and regional engagement trends based on an analysis of 600 million HCP interactions across more than 80% of biopharmas worldwide.

Want to dive deeper?
Below are some of the top insights from previous Veeva Pulse Field Trends Reports. You can also access the full reports for comprehensive data and analysis.

Closing the Gap: New Science, New HCP Expectations

Increasing therapeutic complexity and competition, narrowing windows for launch success, and HCPs’ growing need for deep scientific information require a coordinated commercial strategy to efficiently educate HCPs on new treatments.

Pre-launch Scientific Outreach Accelerates Treatment Adoption by 40%

Prioritizing investments in targeted scientific activities with the right experts sets the stage for faster treatment adoption and, ultimately, commercial success at launch and beyond.

HCP Access Declined from 60% to 45%

Access is back to pre-pandemic levels and HCPs remain highly selective – about half limit access to three or fewer biopharmas. But connected engagement across sales, marketing, and medical is giving HCPs what they need, when they need it.

Synchronize sales and marketing for better outcomes

Help your field and marketing teams engage HCPs with the right omnichannel mix.